Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Biovance, a Dehydrated Decellularized Human Amniotic Membrane Allograft, in Diabetic Foot Ulcers

NCT02506452 is registered in ClinicalTrials.gov with Alliqua BioMedical, Inc as lead sponsor.

NCT NCT02506452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02506452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Biovance, a Dehydrated Decellularized Human Amniotic Membrane Allograft, in Diabetic Foot Ulcers
Lead sponsor
Alliqua BioMedical, Inc
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2015
Completion date
December 31, 2017
Enrollment
51 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers